Placeholder

2012 PharmaVOICE 100 – Who’s on the List by Company

$30.00

Copyright: This PDF purchase is for a Single user for review or filing purposes only. The PDF is watermarked. If you are interested in a PDF reprint to post on your website or distribute electronically, or hard-copy reprints, please contact Marah Walsh at mwalsh@pharmavoice.com.

Product Description

360 Vantage — Mario Martinez II
Agile Therapeutics— Marie Foegh, M.D.
Alkermes— Elliot Ehrich, M.D.
Almac Clinical Technologies— Graham Nicholls
Amgen — Martin VanTrieste, R.Ph.
Appature — Kabir Shahani
The Assay Depot— Kevin Lustig, Ph.D.
Auxilium Pharmaceuticals — Adrian Adams
Ayogo Games — Michael Fergusson
Becton, Dickinson and Company — Betsy Lahue
Blue Chip Healthcare Marketing — Cheryl Dewey
Boehringer Ingelheim — J. Martin Carroll
Bristol-Myers Squibb— Dale Kummerle, Pharm.D.
Cadient Group— Stephen Wray
The CDM Group — Josh Prince
Cegedim Relationship Management— Laurent Labrune
Center for Communication Compliance — Ilyssa Levins
Chandler Chicco Companies— Marianne Eisenmann
Cleave Biosciences— Laura Shawver, Ph.D.
Clinical Ambassador — Allison Kalloo
Clinical Ink — Ed Seguine
Clinical Research Advantage— Mark Hanley
Community Health Systems— Cindy Parrott
Compass IRB — Matt Baker
Comprehend Systems — Rick Morrison
Continuum Health Communications  — Terri Clevenger
Crossix Solutions — Asaf Evenhaim
CSC— Adam Sherlock
DMD/Aptilon — Roger Korman, Ph.D.
DSP Clinical Research — Darlene Panzitta
Dudnyk— Christopher Tobias, Ph.D.
Eisai Pharmatechnology — Sanjit Singh Lamba
EMD Serono — Lisa Costantino
eResearch Technology  — Jeffrey Litwin, M.D.
Genoptix, a Novartis company — Tina Nova, Ph.D.
GenR Media— Andrew Stanger
GSW Worldwide— Leigh Householder
HCB Health— Nancy Beesley
Healthcare Regional Marketing — Jeff Spanbauer
ICC Lowe— Steve Viviano
INC Research — Jim Ogle
Infinity Pharmaceuticals  — Adelene Perkins
Inspired Health Strategies — Dyan Bryson
Intouch Solutions— Faruk Capan
inVentiv Commercial Solutions — Kelly Gratz
Ipsen Biopharmaceuticals  — Cathryn Clary, M.D.
Janssen Research & Development  — Jerry Boscia, M.D.
Janssen Research & Development  — Diego Miralles, M.D.
Janssen Research & Development — Jay Siegel, M.D.
KJT Group — Kenneth Tomaszewski, Ph.D.
Klick Health— Leerom Segal
MakroCare Clinical Research Ltd. — Sreedhar Tirunagari, M.D.
MediciNova — Yuichi Iwaki, M.D., Ph.D.
Medidata Solutions Worldwide — Marco van Doeveren
MedImmune— Steven Walker
Medisys Health  Communications  — Anna Walz
The Michael J. Fox Foundation for Parkinson’s Research— Todd Sherer, Ph.D.
MicroMass Communications  Robert Peters
Millennium: The Takeda Oncology Company— Karen Ferrante, M.D.
MMG— Gaynor Anders
Novartis Pharma — Timothy Wright, M.D.
Novartis Pharmaceuticals  — Patrice Matchaba, M.D.
Ogilvy CommonHealth  Worldwide — Michael Parisi
Optimer Pharmaceuticals— Joe Martinez
Palio— Todd LaRoche
Paragon Bioservices — Marco Chacón, Ph.D.
Parent Project Muscular  Dystrophy — Patricia Furlong
PDR Network— Rich Altus
Pfizer — Scott Richardson
Pfizer — Linda Rosenes
PharmaMed Research — Brad Doerschuk
PHT — Sheila Rocchio
Physicians Interactive Holdings — Donato Tramuto
PPD— Lee Babiss, Ph.D.
PRA— Tami Klerr-Naivar
PSKW — Robert Previdi
Publicis Healthcare Communications Group— Leo Francis, Ph.D.
Publicis Touchpoint  Solutions — Rick Keefer
Purdue Pharma— Mike Innaurato
Qforma— Robert Holmes, Ph.D.
Quintiles — Amir Kalali, M.D.
Quintiles — Kim Boericke
Red Nucleus— Ian Kelly
Roche Diagnostics— Jack Phillips
Rosetta— Shannon Hartley
Roska Healthcare Advertising — Chuck McLeester
Sanofi US— Kathleen Castore
SciFluor Life Sciences — Tobias Ritter, Ph.D.
Selventa — David de Graaf, Ph.D.
Siren Interactive — Wendy White
Star Group Communications — Timmy Garde
Strikeforce Communications — Michael Rutstein
Synteract  Olivia Montaño-Tritz
Topin & Associates— Abby Mansfield
Trio Clinical Resourcing, an Aptiv Solutions company— Betsy Brown
Veeva Systems   Paul Shawah
Vertex Pharmaceuticals— Saru Wade
Walgreen— Jeff Berkowitz
Warp Drive Bio— Alexis Borisy
WorldOne— Peter Kirk

FEEDBACK